Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
AAR CORP. announced it has entered into a definitive agreement to acquire a 65% controlling interest in MRO Holdings, Inc. at an implied enterprise value of approximately $4.0 billion. To fund the transaction, the company launched a private offering of $1.915 billion in senior notes, consisting of $955 million due 2031 and $960 million due 2034.
Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending business combination with Electra Vehicles, Inc., including a new investor presentation and a newsletter detailing Electra's recent developments. The filing highlights Electra's new partnership with Westbrook Racing as its Official Battery Intelligence Partner and its participation in several global industry conferences.
The FDA granted accelerated approval for INOVIO's VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) to reduce the frequency of surgery in adults with Recurrent Respiratory Papillomatosis (RRP). This represents the first U.S. FDA-approved DNA medicine and validates INOVIO's platform technology, with a commercial launch expected in Q1 2027.
“With the approval of VOCERYQ, we believe our DNA medicine platform has the potential to transform the treatment paradigm for RRP by offering a patient-centric treatment option. VOCERYQ is designed to deliver what we understand matters most to patients, which is the reduction of the surgical burden caused by RRP.”
Dr. Jacqueline Shea, INOVIO’s President and Chief Executive Officer
TripAdvisor Divestiture to American Express Travel Related Services Company, Inc. for $700M
Tripadvisor completed the sale of its European online restaurant reservation platform, TheFork, to American Express for $700 million in cash. The deal includes a 12-month transition services agreement to facilitate the separation of the business. Tripadvisor expects to discuss the impact of this significant disposition during its Q3 2026 earnings call.
Value
$700M
Counterparty
American Express Travel Related Services Company, Inc.
Vertical Data Inc. announced it intends to issue shares of common stock in a private placement transaction for gross proceeds of approximately $4.2 million. The company also disclosed a non-binding term sheet for a GPU-as-a-Service arrangement with a cloud provider involving 16,000 NVIDIA GPUs with a potential contract value of $2.8 billion.
Eton Pharmaceuticals Research Collaboration with Baylor College of Medicine
Eton Pharmaceuticals has entered into a license and development agreement with Baylor College of Medicine to evaluate mecasermin (ET-900) for the treatment of infantile and epileptic spasms. The partnership includes an investigator-sponsored Phase 2 clinical study with patient dosing targeted for Q1 2027, following the submission of an Investigational New Drug application to the FDA.
Alpine Income Property Trust Signs $117M M&A Deal with institutional owner
Alpine Income Property Trust completed the acquisition of a 13-property industrial portfolio for $117.3 million from an institutional seller. The portfolio totals 1.9 million square feet across 11 states and is 100% leased to nine tenants under absolute triple-net leases. The acquisition was funded using borrowings from the company's revolving credit facility.
Atrium Therapeutics announced nonclinical data for its lead therapy ATR 1072 showing reversal of cardiac glycogen accumulation and improvement in hypertrophy in a mouse model of PRKAG2 syndrome. The company plans to present these findings at the American Heart Association Scientific Sessions 2026 and expects initial Phase 1/2 clinical proof-of-concept data in the second half of 2027.
Lazard Signs $742M M&A Deal with Campbell Lutyens Holdings Limited
Lazard completed its acquisition of Campbell Lutyens, launching a new global private capital advisory business called Lazard CL. The total consideration includes approximately $448.8 million in initial equity (9.65 million shares at $46.50), $93.2 million in initial cash, $115 million in deferred consideration, and up to $85 million in contingent earn-outs.
Value
$742M
Counterparty
Campbell Lutyens Holdings Limited
“We are thrilled to launch our third global business, Lazard CL. By pairing leading global positions in primary fundraising and secondary advisory with our world-class M&A, capital markets, and restructuring expertise, we are deepening the connectivity between our advisory businesses and strengthening our reach across both the largest strategic transactions and private capital activity.”
BHAV Acquisition Corp II (SPAC) consummated its initial public offering (IPO) of 10,000,000 units at $10.00 per unit, generating gross proceeds of $100 million. Each unit consists of one Class A ordinary share and one right to acquire one-fourth of a share upon completion of a business combination. The company granted underwriters a 45-day option to purchase up to an additional 1.5 million units to cover over-allotments.
Regen Biopharma entered into a $10 million equity line of credit with Coventry Enterprises, allowing the company to sell shares of common stock at a 20% discount to market prices over a 36-month term. Additionally, the company issued a $125,000 10% unsecured promissory note to Coventry, using a portion of the proceeds to satisfy $71,557 in existing convertible debt.
Dorchester Minerals M&A Deal with Hillside Exploration Assets, LLC
Dorchester Minerals, L.P. completed the acquisition of mineral and royalty interests covering approximately 4,300 net royalty acres in the Williston Basin, North Dakota. The transaction was structured as a non-taxable contribution and exchange where the Partnership issued 1,250,000 common units to Hillside Exploration Assets, LLC in exchange for the properties.
Aptevo Therapeutics filed a prospectus supplement to its existing at-the-market (ATM) offering agreement with Roth Capital Partners, allowing for the potential sale of up to $2.3 million in common stock. The company disclosed that it has already raised $11.8 million in gross proceeds through the sale of 303,157 shares under the program to date.
Digital Realty Trust is registering the resale of common stock previously issued as consideration for its October 19, 2026, acquisition of an additional 16% interest in the Teraco joint venture. The shares were issued following the exercise of a put right by certain third-party partners in the joint venture.
Cyngn Inc. notified Nasdaq that it will fall out of compliance with Audit Committee requirements following the resignation of director Karen Macleod on November 3, 2026. The company will have a cure period until its next annual meeting or November 3, 2027, to appoint a third independent director and regain compliance. Ms. Macleod's departure was not due to any disagreement with the company's operations or policies.
Zoned Properties, Inc. completed the sale of substantially all of its business and assets to BPB Partners, LLC on October 30, 2026. In connection with the closing, the company redeemed 100% of its outstanding preferred stock for $2 million and entered into severance agreements with its top executives. The buyer, BPB Partners, is owned by the company's own Chairman/CEO, President/COO, and another individual.
Porch Group and Porch Reciprocal Exchange entered into an at-the-market (ATM) distribution agreement with StoneX Financial Inc. to sell up to 15 million shares of common stock. The offering includes 10 million shares currently held by the Reciprocal to convert non-admitted assets into cash and 5 million new shares to be issued by the company for general corporate purposes.
OpenWorld, Inc. closed a registered direct public offering of 1,494,084 shares of common stock and pre-funded warrants to purchase 1,023,901 shares, alongside Series A and Series B common stock purchase warrants. The company received gross proceeds of approximately $3.5 million before deducting placement agent fees and expenses. Maxim Group LLC served as the sole placement agent for the offering.
BioXcel Therapeutics Divestiture to Teva Pharmaceuticals International GmbH for $57.5M
BioXcel Therapeutics completed the sale of substantially all of its neuroscience assets, including IGALMI and BXCL501, to Teva Pharmaceuticals for $57.5 million in upfront cash. The company is also eligible for up to $67.5 million in development milestones and $20 million in commercial milestones. The sale was conducted under Section 363 of the Bankruptcy Code as part of BioXcel's Chapter 11 proceedings.
Rapport Therapeutics entered into an underwriting agreement for a public offering of 8,333,334 shares of common stock and 1,190,476 pre-funded warrants at a price of $21.00 per share. The underwriters fully exercised their option to purchase an additional 1,428,571 shares, bringing estimated net proceeds to approximately $215.7 million. The funds are intended to support clinical trials for RAP-219 and other research and development activities.
Koil Energy Solutions entered into a securities purchase agreement to raise approximately $5.6 million through a private placement (PIPE) of 1,330,372 shares and 919,628 pre-funded warrants. The proceeds are intended for working capital and investments in rental equipment to support growth in deepwater energy production services.
Value
$5.6M
“This financing is intended to support the next phase of our growth by allowing us to expand our rental equipment fleet and strengthen our service capabilities to better serve our customers. Our preliminary third-quarter results reflect the continued progress of the business, and we remain focused on deploying capital strategically to support long-term growth.”
Annovis Bio received a deficiency notice from the NYSE for failing to maintain a minimum average market capitalization of $50 million and stockholders' equity of $50 million over a 30-day period. The company has 45 days to submit a compliance plan and 9 months to regain compliance to avoid delisting. During this period, the stock will continue to trade under the symbol 'ANVS' with an added '.BC' designation.
Alset Inc. received a deficiency notice from Nasdaq on October 28, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive trading days. The company has until April 26, 2027, to regain compliance and intends to resolve the deficiency, potentially through a previously announced 1-for-5 reverse stock split.
Trico Bancshares / M&A Deal with First Hawaiian, Inc.
TriCo Bancshares stockholders approved the company's acquisition by First Hawaiian, Inc. at a special meeting held on October 29, 2026. The transaction, which involves TriCo merging into a subsidiary of First Hawaiian followed by a second-step merger into First Hawaiian, is expected to close later in 2026 subject to customary closing conditions.
Utz Brands M&A Deal with Intersnack Group GmbH & Co. KG
Utz Brands provided a status update on its pending merger with Intersnack Group, announcing that CEO Howard Friedman will depart the company effective November 30, 2026, following the closing of the transaction. The company also confirmed a special meeting of stockholders is scheduled for November 13, 2026, to vote on the merger which will result in Utz becoming a private company.
Accendra Health received a deficiency notice from the NYSE for failing to maintain an average market capitalization and stockholders' equity of at least $50.0 million. The company has 45 days to submit a business plan to regain compliance within 18 months and its stock will continue to trade on the exchange during this period.
Xcel Energy Inc. entered into a new equity distribution agreement to establish an at-the-market (ATM) offering program for up to $6.0 billion of its common stock. This program replaces a prior ATM program from May 2026, which was terminated with approximately $448.6 million in unsold capacity. The company may sell shares through various sales agents or enter into forward sale agreements with forward purchasers.
Public Storage and its subsidiary Public Storage Operating Company (PSOC) entered into an underwriting agreement on October 29, 2026, for a new securities offering. The filing indicates the establishment of an underwriting arrangement for the issuance of securities, which typically involves the sale of equity or debt to raise capital.
First Hawaiian, Inc. and TriCo Bancshares announced that stockholders of both companies have approved their definitive merger agreement. The transaction, originally announced in July 2026, involves TriCo merging into First Hawaiian and is expected to close later in 2026 subject to remaining customary closing conditions.
Sow Good Inc. and its subsidiary entered into a second extension letter to a previously announced Share Purchase Agreement with Ryzon Materials Limited and other sellers. The amendment extends the 'Sunset Date' for the pending acquisition from October 2026 to December 15, 2026.